Drug name - Tyvaso
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US9604901 | UNITED THERAP | Process to prepare treprostinil, the active ingredient in Remodulin® |
Dec, 2028
(6 years from now) | |
| US9593066 | UNITED THERAP | Process to prepare treprostinil, the active ingredient in remodulin® |
Dec, 2028
(6 years from now) | |
| CN103274926A | UNITED THERAP | Process To Prepare Treprostinil, The Active Ingredient In Remodulin |
Dec, 2028
(6 years from now) | |
| CN101903324B | UNITED THERAP | A Kind Of Preparation Of Active Composition In Remodulin Curved Latanoprost Is Improved Method |
Dec, 2028
(6 years from now) | |
| CN101903324A | UNITED THERAP | An Improved Process To Prepare Treprostinil, The Active Ingredient In Remodulin |
Dec, 2028
(6 years from now) | |
| CN103274926B | UNITED THERAP | An Improved Method For Preparing Active Components In The Curved Remodulin |
Dec, 2028
(6 years from now) | |
| IN201003640P4 | UNITED THERAP | An Improved Process To Prepare Treprostinil,The Active Ingredient In Remodulin |
Dec, 2028
(6 years from now) | |
| IN287697B | UNITED THERAP | An Improved Process To Prepare Treprostinil, The Active Ingredient In Remodulin |
Dec, 2028
(6 years from now) | |
| EP2252570A1 | UNITED THERAP | An Improved Process To Prepare Treprostinil, The Active Ingredient In Remodulin ® |
Dec, 2028
(6 years from now) | |
| EP2252570B1 | UNITED THERAP | An Improved Process To Prepare Treprostinil, The Active Ingredient In Remodulin ® |
Dec, 2028
(6 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10716793 | UNITED THERAP | Treprostinil administration by inhalation |
May, 2027
(4 years from now) | |
| US10376525 | UNITED THERAP | Treprostinil administration by inhalation |
May, 2027
(4 years from now) | |
| US9339507 | UNITED THERAP | Treprostinil administration by inhalation |
Mar, 2028
(5 years from now) | |
| US9358240 | UNITED THERAP | Treprostinil administration by inhalation |
May, 2028
(5 years from now) | |
Drugs and Companies using TREPROSTINIL ingredient
Treatment: Method of treating pulmonary hypertension by administering treprostinil or a salt thereof by inhalation using a device
Dosage: SOLUTION;INHALATION
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 0.6MG/ML | SOLUTION;INHALATION | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.